Opko Health Inc OPK

NAS: OPK | ISIN: US68375N1037 1/08/2025

1,190 USD (-7,03%)

(-7,03%) 1/08/2025

Grafiek Opko Health Inc

Grafiek Opko Health Inc

1 dag1d -7,03%
1 week1w -11,85%
1 maand1m -12,50%
3 maanden3m -12,50%
6 maanden6m -20,67%
1 jaar1j -9,16%
5 jaar5j -77,76%

Opko Health Inc in het nieuws

Toon enkel gratis nieuws

11 maart 2025 · Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses · Persbericht

2 juli 2024 · NextPlat Expands E-Commerce Program in China to Include Broad Retail Distribution and Adds Digital/Social Media Marketing Capabilities with New Marketing Partner · Persbericht

28 maart 2024 · Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business · Persbericht

28 februari 2024 · NextPlat Opens OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China on March 1st · Persbericht

5 februari 2024 · NextPlat Receives Initial Approvals to Launch OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China · Persbericht

7 november 2023 · BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™ · Persbericht

29 september 2023 · Thinking about buying stock in Blue Apron Holdings, OceanPal, OPKO Health, Bionomics, or Aytu Biopharma? · Persbericht

9 februari 2023 · BioReference Now Offers the Only FDA-Approved Dual-Stain Triage Test to Enhance Cervical Cancer Screenings · Persbericht

16 maart 2022 · GeneDx Announces Discovery of 200 New and Expanded Genetic Conditions · Persbericht

1 maart 2022 · Saol Therapeutics and GeneDx, Inc. Collaborate to Detect Patients with Rare Mitochondrial Disease · Persbericht

Profiel Opko Health Inc

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Website: www.opko.com

Hoofdzetel: Miami, Florida Verenigde Staten

CEO: Phillip Frost

Werknemers: 339

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe